PRESS RELEASE published on 04/02/2025 at 07:30, 9 months 29 days ago Informations privilégiées / Autres communiqués Nomination d’Amit Munshi en tant que Président du Conseil d’Administration chez Sensorion, société de biotechnologie spécialisée dans les thérapies auditives. Annonce du départ de M. Furey Biotechnologie Conseil D'administration Sensorion Thérapies Auditives Amit Munshi
BRIEF published on 03/26/2025 at 07:35, 10 months 6 days ago Sensorion rejoint la conférence Van Lanschot Kempen à Amsterdam Biotechnologie Investisseurs Conference Sensorion Perte Auditive
BRIEF published on 03/26/2025 at 07:35, 10 months 6 days ago Sensorion joins the Van Lanschot Kempen conference in Amsterdam Investors Biotechnology Conference Sensorion Hearing Loss
PRESS RELEASE published on 03/26/2025 at 07:30, 10 months 6 days ago Informations privilégiées / Autres communiqués Sensorion annonce sa participation à la conférence Van Lanschot Kempen dédiée aux sciences de la vie à Amsterdam. La société présente ses thérapies innovantes pour la perte auditive Biotechnologie Conference Sciences De La Vie Sensorion Thérapies Auditives
PRESS RELEASE published on 03/26/2025 at 07:30, 10 months 6 days ago Inside Information / Other news releases Sensorion announces participation at Van Lanschot Kempen Conference Life Sciences in Amsterdam on April 2-3, 2025. Company focuses on developing therapies for hearing loss disorders Life Sciences Sensorion Amsterdam Hearing Loss Therapies Van Lanschot Kempen Conference
BRIEF published on 03/14/2025 at 07:35, 10 months 18 days ago Sensorion : Bilan 2024 et Perspectives pour 2025 Résultats Financiers Investissements Thérapies Géniques SENS-401 SENS-501
BRIEF published on 03/14/2025 at 07:35, 10 months 18 days ago Sensorion: 2024 Review and Outlook for 2025 Financial Results Investments SENS-401 SENS-501 Gene Therapies
PRESS RELEASE published on 03/14/2025 at 07:30, 10 months 18 days ago Informations privilégiées / Communiqué sur comptes, résultats Sensorion présente ses résultats financiers pour l’exercice 2024, fait le point sur ses activités et annonce la mise à disposition du rapport annuel. Renforcement financier, essais cliniques avancés Résultats Financiers Innovation Scientifique Thérapie Génique Études Cliniques Sensorion
PRESS RELEASE published on 03/14/2025 at 07:30, 10 months 18 days ago Inside Information / News release on accounts, results Sensorion reports full-year 2024 results and provides corporate update with significant milestones achieved in gene therapy clinical trials and financial highlights. Company well positioned for growth in 2025 Clinical Trials Financial Highlights Gene Therapy Full-year Results Sensorion
BRIEF published on 03/07/2025 at 07:35, 10 months 25 days ago Sensorion conclut le recrutement pour l'essai NOTOXIS sur le SENS-401 Essai Clinique Sensorion SENS-401 Cisplatine Ototoxicité
Published on 02/02/2026 at 00:05, 3 hours 22 minutes ago Resource Upgrade Drilling Begins on Challenger Open Pits
Published on 01/31/2026 at 03:15, 2 days ago Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 01:40, 2 days 1 hour ago Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 02/02/2026 at 02:50, 37 minutes ago Xinhua Silk Road: Ecosystem and sustainability redefine global automotive brand value: report
Published on 02/01/2026 at 20:25, 7 hours 2 minutes ago WHO Makes Historic Pivot to County-Level Governance, Validating "Bottom-Up" Climate-Health Model in Tropical Southern China
Published on 01/31/2026 at 15:54, 1 day 11 hours ago EQS-Adhoc: Wolford AG: Capital increase will not be implemented
Published on 01/31/2026 at 12:25, 1 day 15 hours ago JOHNNIE WALKER TOASTS MUSIC'S BIGGEST WEEKEND WITH THE GO GO HIGHBALL
Published on 01/30/2026 at 18:40, 2 days 8 hours ago ICADE - Bilan semestriel du contrat de liquidite
Published on 01/30/2026 at 17:45, 2 days 9 hours ago Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 17:45, 2 days 9 hours ago Schneider Electric lance une augmentation de capital réservée aux salariés
Published on 01/30/2026 at 08:30, 2 days 18 hours ago Claude Bernard lance Senior+, un assistant IA conçu pour améliorer la prise en charge des patients les plus âgés
